淋巴瘤

预约门诊

Lymphoma staging

If you're diagnosed with lymphoma, the next step is to determine the cancer's extent, called the stage. Imaging tests, blood tests and biopsies may be used to determine the stage of your lymphoma. Your healthcare team uses the cancer stage to help create your treatment plan.

The stages of lymphoma may vary slightly depending on which type you have. Overall, the stages range from 1 to 4:

  • Stage 1 lymphoma. At stage 1, lymphoma affects only one lymph node region or one site outside of the lymph nodes.
  • Stage 2 lymphoma. A stage 2 lymphoma involves two or more lymph node regions on the same side of the diaphragm.
  • Stage 3 lymphoma. At stage 3, lymphoma involves lymph node regions on both sides of the diaphragm.
  • Stage 4 lymphoma. A stage 4 lymphoma involves regions outside of the lymph nodes.

Lymphoma prognosis

The cancer prognosis tells you how likely it is that the cancer can be treated or cured. Your prognosis may depend on:

  • Your age.
  • Your overall health.
  • The type of lymphoma you have.
  • The cancer's stage.
  • Your blood test results.

Talk with your healthcare team about your prognosis if you want to know what to expect. Members of your healthcare team can explain what they consider when thinking about your prognosis.

申请预约
诊断与治疗
Dec. 20, 2024

Living with 淋巴瘤?

Connect with others like you for support and answers to your questions in the CAR-T Cell Therapy support group on Mayo Clinic Connect, a patient community.

CAR-T Cell Therapy Discussions

Lori, Volunteer Mentor
My Bone Marrow Transplant (BMT/SCT) story: Will you share yours?

776 Replies Tue, Sep 16, 2025

Bob, Alumni Mentor
CAR-T cell Therapy: Joint and muscle pain

50 Replies Fri, Sep 05, 2025

Heather McFarland
A Summary of My Multiple Myeloma

47 Replies Fri, Aug 29, 2025

See more discussions
  1. Lymphoma – Non-Hodgkin. Cancer.Net. https:www.cancer.net/cancer-types/41246/view-all. Accessed Dec. 18, 2023.
  2. Lymphoma – Patient version. National Cancer Institute. https://www.cancer.gov/types/lymphoma. Accessed Dec. 18, 2023.
  3. What causes non-Hodgkin lymphoma? American Cancer Society. https://www.cancer.org/cancer/types/non-hodgkin-lymphoma/causes-risks-prevention/what-causes.html. Accessed Dec. 21, 2023.
  4. Elsevier Point of Care. Clinical Overview: Hodgkin lymphoma. https://www.clinicalkey.com. Accessed Dec. 21, 2023.
  5. Freedman A, et al. Clinical presentation and initial evaluation of non-Hodgkin lymphoma. https://www.uptodate.com/contents/search. Accessed Jan. 30, 2024.
  6. Lymphoma – Non-Hodgkin: Diagnosis. https://www.cancer.net/cancer-types/lymphoma-non-hodgkin/diagnosis. Accessed Dec. 22, 2023.
  7. Non-Hodgkin lymphoma treatment (PDQ) – Patient version. National Cancer Institute. https://www.cancer.gov/types/lymphoma/patient/adult-nhl-treatment-pdq. Accessed Jan. 1, 2024.
  8. Brondfield S, et al. Developing a community for patients with cancer through longer-term art therapy. Oncology Practice. 2020; doi:10.1200/OP.20.00419.
  9. Distress management. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1431. Accessed Jan. 3, 2024.
  10. Coping with cancer. Cancer.Net. https://www.cancer.net/coping-with-cancer. Accessed Jan. 4, 2024.
  11. Robetorye R, et al. Incorporation of digital gene expression profiling for cell-of-origin determination (Lymph2Cx Testing) into the routine work-up of diffuse large B-Cell lymphoma. Journal of Hematopathology. 2019; doi:10.1007/s12308-019-00344-0.
  12. Laurent C, et al. Impact of expert pathologic review of lymphoma diagnosis: Study of patients from the French Lymphopath Network. Journal of Clinical Oncology. 2017; doi:10.1200/JCO.2016.71.2083.
  13. Member institutions. Alliance for Clinical Trials in Oncology. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=%2FPublic%2FInstitutions. Accessed April 14, 2024.
  14. Membership institution lists. NRG Oncology. https://www.nrgoncology.org/About-Us/Membership/Member-Institution-Lists. Accessed April 14, 2024.

淋巴瘤

CON-20304579